Trial intelligence / Profile preview

Intravenous magnesium sulfate for treatment of chronic obstructive pulmonary disease

IRCT2014111519962N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD), sponsored by Mashhad University of Medical Sciences. Started Oct 2017; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on IRCT2014111519962N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014111519962N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call